Dr. Rachel D. Lusby

Noelle Cloven is an Obstetrics and Gynecologist and an Oncologist practicing medicine in Fort Worth, Texas. Dr. Cloven is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, and Endometrial Cancer. Dr. Cloven is board certified in Obstetrics & Gynecology- American Board Of Obstetrics And Gynecology, Obstetrics And Gynecology- American Board Of Obstetrics And Gynecology, Gynecologic Oncology- American Board Of Obstetrics & Gynecology/Gynecologic Oncology, and Gynecologic Oncology- American Board Of Obstetrics And Gynecology. Dr. Cloven is currently accepting new patients.

Dr. Ripperda attended medical school at Rush Medical College in Chicago, IL. He then completed a residency in Obstetrics & Gynecology and a fellowship in Female Pelvic Medicine and Reconstructive Surgery (also known as Urogynecology) at UT Southwestern Medical Center/Parkland Hospital. During his fellowship, Dr. Ripperda was the recipient of the Best Basic Science Manuscript at the 2016 American Urogynecologic Society national meeting in Denver, CO. This work was published the July 2017 edition of the journal Menopause. His clinical interests include the treatment of overactive bladder, urinary incontinence, pelvic organ prolapse, fecal incontinence and urinary tract fistula. Dr. Ripperda offers a variety of non-surgical and surgical options and tailors his approach to the wishes and needs of each individual patient. His surgical interests include vaginal, laparoscopic, robotic and abdominal approaches to the treatment of pelvic floor disorders. Dr. Ripperda lives in Fort Worth, TX with his wife where they live with their two children and two dogs. His hobbies include golf, traveling and collecting coins and vintage fountain pens. Dr. Ripperda is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Frequent or Urgent Urination, Urinary Incontinence, Stress Urinary Incontinence, Rectocele, and Oophorectomy. Dr. Ripperda is board certified in Urogynecology And Reconstructive Pelvic Surgery- American Board Of Obstetrics And Gynecology, Obstetrics & Gynecology- American Board Of Obstetrics And Gynecology, Urogynecology And Reconstructive Pelvic Surgery- American Board Of Obstetrics & Gynecology/Female Pelvic Medicine And Reconstructive Surgery, Urogynecology And Reconstructive Pelvic Surgery- American Board Of Obstetrics & Gynecology/Urogynecology And Reconstructive Pelvic Surgery, and Female Pelvic Medicine And Reconstructive Surgery- American Board Of Obstetrics & Gynecology/Female Pelvic Medicine And Reconstructive Surgery. Dr. Ripperda is currently accepting new patients.

"""Dr. Bevan grew up in Fort Worth, TX, and completed both medical school and residency at UT Southwestern Medical Center in Dallas, where she was honored with the Outstanding Resident Award by the Southwestern Gynecologic Assembly. She also spent an additional year as an Assistant Professor at UT Southwestern specializing in gynecologic surgery and emergency women's care.Dr. Bevan has conducted research in family planning and gynecologic cancer. She has presented her research at the Western Association of Gynecologic Oncologists. She has also volunteered for a number of efforts, including a pediatric rotation in Bangalore, India, and a family health program in Oaxaca, Mexico.Dr. Bevan is board certified by the American Board of Obstetrics and Gynecology, a Fellow of the American Congress of Obstetricians and Gynecologists and a member of the Texas Medical Association and the American Medical Association. She and her husband, Scott, are the proud parents of Zachary and Natalie.""". Dr. Bevan is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Vaginal Cysts, Vaginal Dryness, Carney Complex, Intrauterine Device Insertion, and Hormone Replacement Therapy (HRT). Dr. Bevan is board certified in Obstetrics & Gynecology- American Board Of Obstetrics And Gynecology. Dr. Bevan is currently accepting new patients.